Alangcas, Jhon Cloyd L.
HRN: 23-44-93 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
10/12/2024
CEFUROXIME 750MG (VIAL)
10/12/2024
10/19/2024
IV
400
EVERY 8 HOURS
PCAP B
Waiting Final Action
Indication: Empiric Type of Infection: PneumoniaFebrile Neutropenia Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes